Japanese content trade group CODA — whose members include award-winning animation house Studio Ghibli — issued a letter to OpenAI demanding the AI company stop using their content to train its Sora 2 ...

Japanese trade association CODA says Sora 2’s opt-out policy may have violated copyright law. Japanese trade association CODA says Sora 2’s opt-out policy may have violated copyright law. is a news ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

The Chat feature of Google AI Studio allows users to interact with Gemini models in a conversational format. This feature can make everyday tasks easier, such as planning a trip itinerary, drafting an ...

The White House said Tuesday it will use money from tariff revenue to fund a supplemental nutrition program facing a funding shortage amid the ongoing government shutdown. White House press secretary ...

Starting today, customers with U.S.-based environments can add computer use to their agents directly as a tool - meaning agents can work directly with websites and applications. Computer use, now in ...

A new Medicare pilot program will require prior authorization for certain medical procedures, using AI to approve or deny coverage A new program from the Centers for Medicare and Medicaid Services ...

What if you could build your own AI assistant—one that understands your unique needs and works tirelessly to simplify your day-to-day tasks? With Microsoft Copilot Studio, this isn’t just a futuristic ...

The Sharpe-Walentas Studio Program is one of New York City’s most competitive artist residency programs. Zlatko Batistich Observer recently spoke with Ariel Willmott, director of cultural affairs for ...

BOSTON, July 4, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery ...

BOSTON, July 4, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery ...